Toxic Exposures May Alter Epigenetic Clocks in Reproductive-Age Women
New findings suggest environmental toxic exposures can shift epigenetic aging markers.
Feb 20, 2026 • 0 likes • 0 comments
Dive into the pulse of the microscopic world, explore synthetic evolutionary paths, and get better bio-tech insights.
New findings suggest environmental toxic exposures can shift epigenetic aging markers.
Feb 20, 2026 • 0 likes • 0 comments
The FDA approved Casgevy and Lyfgenia in December 2023, including the first FDA-approved CRISPR/Cas9 therapy for sickle cell disease in patients 12 and older.
Researchers report secondary social and health harms from drug deaths extending beyond mortality counts.
Get weekly discovery roundups in your inbox.